Steven Pittler, Ph.D., professor in the Department of Vision Sciences in the UAB School of Optometry, has received a four-year, $1.4 million National Institutes of Health National Eye Institute grant.
This work will focus on a protein that is unique to the eye and is required for sight. When the gene that encodes this protein is defective, it leads to the ocular disorder retinitis pigmentosa, a progressive hereditary form of blindness.
Pittler, who is also director of the Vision Science Research Center, will study the function of the protein to devise treatments for the disease. The grant is titled “Analysis of retina rod photoreceptor GARP and cGMP-gated channel.”
“This application seeks to identify fundamental properties of the genes’ encoded proteins that will provide essential information needed to develop a treatment, as there is no established treatment for this disease, which affects a significant portion of the United States and world populations,” Pittler said.
Researcher’s lifesaving raceways invention goes internationalUAB engineering professor Dean Sicking’s SAFER Barriers will be installed at the historic Le Mans Race Circuit.posted 5 days ago 937 viewsS&P raises UAB bond ratings on very strong financial and enterprise profilesIdentifying a stable outlook and UAB’s very strong enterprise and financial profile, S&P Global Ratings has raised its rating on various series of general revenue bonds issued by The University of Alabama System Board of Trustees on behalf of UAB.posted 5 days ago 629 viewsHIV vaccine design should adapt as HIV virus mutatesResearchers from UAB, Emory and Microsoft demonstrate that HIV has evolved to be pre-adapted to the immune response, worsening clinical outcomes in newly infected patients.posted 8 days ago 2252 viewsMore than 10 risk factors identified in readmission of pediatric neurosurgery patientsBig data provides insight into patient readmission after pediatric neurosurgery.posted 7 days ago 1072 viewsRheumatoid arthritis: seeking an answer, cell by cellUAB researchers will use a $1.8 million grant to look at single cells for altered expression of the interferon gamma receptor gene.posted 12 days ago 1814 viewsA focus on homelessness as VA and UAB researchers mark National VA Research WeekVA Research support for UAB clinicians and scientists has been important for six decades.posted 13 days ago 1138 viewsRural children at risk for worse health outcomes, higher health care costsResearchers at UAB look to integrate health care within rural communities to improve care for children.posted 12 days ago 1769 views
After 30 years at UAB, VP Marchase announces plans to retireLongtime VP for Research and Economic Development Richard B. Marchase, Ph.D., plans to retire at the end of 2016. During his tenure, UAB annual research expenditures grew from $331 million to $510 million.posted 14 days ago 2141 viewsResearchers find potential breakthrough in binge-eating disorder treatmentA treatment used for depression, Parkinson’s disease and autism shows promise to alleviate obesity in binge-eating disorder patients.posted 15 days ago 3171 viewsUAB Hospital recognized for decreasing inappropriate use of antibioticsAntibiotic use in acute and long-term care facilities is a focus of UAB’s antibiotic stewardship program.posted 18 days ago 1921 viewsTen-year-old finds relief from rare eyelash growthDaniel Deligio, O.D., treats a rare disease and provides successful treatment plan for Sam Peppers.posted 19 days ago 1944 viewsParkinson’s disease pathogenesis is reduced in a rat model using a cell-signaling inhibitor drugResults show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.posted 21 days ago 2307 viewsUAB driving simulator lab has national debut live on TODAYCutting-edge technology and research brings national attention to UAB.posted 25 days ago 3262 viewsStudy shows how different people respond to aspirin — an important cardioprotective drugUnderstanding how people respond to aspirin is key in terms of knowing who will benefit from it.posted 26 days ago 1403 viewsDepartment of Ophthalmology to host 2016 Clinical and Research SymposiumThe University of Alabama at Birmingham School of Medicine and Department of Ophthalmology will host the 2016 Annual Clinical and Research Symposium on May 13-14 at the Westin Birmingham.posted 26 days ago 705 viewsStudy to test ways to improve cognitive functioning of older adults with HIVUAB School of Nursing Professor David Vance, Ph.D., received a five-year, $2.86 million R01 grant to test ways of improving cognitive function in older adults with HIV.posted 28 days ago 1182 viewsFirst-of-its-kind driving simulator lab at UAB powered by donation from Honda Manufacturing of Alabama and ALDOTThe facility will enable new distracted-driving research, addressing a major public health issue that is a leading cause of highway and traffic-related injuries and death.posted a while back 3140 viewsUAB looking for healthy adults to participate in study on blood pressureThe UAB Division of Rheumatology and Immunology and the Division of Cardiovascular Disease look at effects of Allopurinol in healthy adults age 18-40.posted a while back 1265 viewsUAB observational study of Zika virus infection during pregnancy begins in BrazilUAB professor leads study in Brazil to help further understand the effects of Zika virus during pregnancy.posted a while back 2501 viewsUAB Medical Genomics Laboratory refines its genetic testing technologyCustomized deep-coverage, next-generation sequencing will replace the current state-of-the-art approach.posted a while back 1581 views